Vontobel Holding’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,827	Closed	-$283K	–	1118
2023 Q3	$283K	Hold	25,827	–	–	﹤0.01%	906
2023 Q2	$334K	Buy	25,827 +9,146	+55%	+$118K	﹤0.01%	898
2023 Q1	$200K	Hold	16,681	–	–	﹤0.01%	987
2022 Q4	$229K	Buy	+16,681	New	+$229K	﹤0.01%	956